Chloroquine Study Analysis and Misinterpretation

It's laughable.

Says here, malaria drug chloroquine does not inhibit SARS CoV 2.

So this study came out this week, and this is

in tissue culture. So I looked at the study, and I thought that's interesting.

I don't know what happened there, but let me look at it.

So then I saw KLU3 lung cells.

So they said, hey, it may work in kidney cells,

but it doesn't work in lung cells.

So in our evidence, yeah, it can work in vitro and

kidney cells, but not in lung cells.

So I thought, well, that's interesting.

So I worked at MD Anderson. I was in ocular oncology, and I thought about it.

I said, I've heard of that cell line for KLU3 lungs. It's an adenocarcinoma.

It's a lung cancer cell.

So I called, I tweeted, I corresponded with the author, and I said, I am

so happy for your study.

You just showed one of the most amazing things that I've ever seen.

I never thought I would see something so clear.

You just proved that when virus is around and chloroquine is around,

chloroquine will let the virus attack a cancer cell.

Think about that.

So it will protect a normal cell,

but chloroquine

will not protect a cancer cell because they're de differentiated.

The receptors are different.

I mean, think about that. So I turned them back. I said, thank you.

You completely misinterpreted the data,

and you hid the fact. They hid it. They put it all the way down.

As you know, you have to look for the data set.

So I found it in the appendix, in little letters, KLU3 lung cells.

This is the disinformation campaign that we are faced with.

They put out a big thing, and they said, oh, it doesn't work.

They put it on Medical Express.

That's it for chloroquine.

It's unlikely to work against SARS CoV 2. We just proved it.

No, you proved chloroquine is one of the smartest drugs in history.

It will let the viruses attack cancer cells, but not normal cells.